Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT

被引：90

作者：

Schmid, Christoph ^{[1
]}

Labopin, Myriam ^{[2
,3
]}

Schaap, Nicolaas ^{[4
]}

Veelken, Hendrik ^{[5
]}

Schleuning, Michael ^{[6
]}

Stadler, Michael ^{[7
]}

Finke, Juergen ^{[8
]}

Hurst, Erin ^{[9
]}

Baron, Frederic ^{[10
]}

Ringden, Olle ^{[11
]}

Bug, Gesine ^{[12
]}

Blaise, Didier ^{[13
]}

Tischer, Johanna ^{[14
]}

Bloor, Adrian ^{[15
]}

Esteve, Jordi ^{[16
]}

Giebel, Sebastian ^{[17
,18
]}

Savani, Bipin ^{[19
]}

Gorin, Norbert-Claude ^{[2
,3
]}

Ciceri, Fabio ^{[20
]}

Mohty, Mohamad ^{[2
,3
]}

Nagler, Anton ^{[21
]}

机构：

[1] Univ Munich, Dept Haematol & Oncol, Klinikum Augsburg, Stenglinstr 2, D-86156 Augsburg, Germany

[2] Univ Paris 06, Paris, France

[3] EBMT Data Off, Paris, France

[4] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[5] Leiden Univ Hosp, BMT Ctr Leiden, Leiden, Netherlands

[6] Deutsch Klin Diagnost, KMT Zentrum, Wiesbaden, Germany

[7] Hannover Med Sch, Dept Haematol & Oncol, Hannover, Germany

[8] Univ Freiburg, Dept Med Haematol & Oncol, Freiburg, Germany

[9] NCCN Freeman Hosp, Bone Marrow Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England

[10] Univ Liege, Dept Med, Div Haematol, Liege, Belgium

[11] Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Therapeut Immunol, Karolinska Inst, Stockholm, Sweden

[12] Univ Klinikum, Dept Med 2, Haematol & Oncol, Frankfurt, Germany

[13] Marseille Inst Paoli Calmettes, Programme Transplantat & Therapie, Cellulaire Ctr Rech Cancerol, Marseille, France

[14] Ludwig Maximilians Univ Munchen, Dept Med 3, Haematol & Oncol, Munich, Germany

[15] Christie NHS Fdn Trust, Stein Cell Transplantat Unit, Manchester, Lancs, England

[16] Hosp Clin Barcelona, IDIBAPS, Dept Haematol, Barcelona, Spain

[17] Maria Sklodowska Curie Canc Ctr, Gliwice, Poland

[18] Inst Oncol, Gliwice Branch, Gliwice, Poland

[19] Vanderbilt Univ Sch Med, Long Term Transplant Clin, Nashville, TN USA

[20] Univ Milan, Dept Haematol, Osp San Raffaele, Milan, Italy

[21] Chaim Sheba Med Ctr, Tel Hashomer, Israel

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 184卷 / 05期

关键词：

acute leukaemia; allogeneic stem cell transplantation; DLI; relapse prevention; ACUTE MYELOID-LEUKEMIA; STAGE ACUTE-LEUKEMIA; SURVIVAL; PREVENTION; ANTIGEN;

D O I：

10.1111/bjh.15691

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Strategies for relapse prevention after allogeneic transplantation in acute leukaemia are warranted. A registry-based matched-pair analysis evaluated the efficacy of prophylactic donor lymphocyte infusion (proDLI). Adults receiving proDLI in complete remission (CR) and controls were pair-matched for age, diagnosis, cytogenetics, stage, donor, gender, conditioning and T-cell depletion. Eighty-nine pairs were identified (median follow-up: 6.9 years). Within the entire cohort, no difference was observed. However, among patients with high-risk acute myeloid leukaemia (AML) (unfavourable cytogenetics and/or transplanted beyond first CR), proDLI recipients had improved overall survival (69.8% vs. 40.2% in controls, P = 0.027). ProDLI has moderate efficacy, but can contribute to improved outcome in high-risk AML.

引用

页码：782 / 787

页数：6

共 50 条

[1] Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation
Nagler, Arnon
Labopin, Myriam
Dholaria, Bhagirathbhai
Finke, Juergen
Brecht, Arne
Schanz, Urs
Niittyvuopio, Riitta
Neubauer, Andreas
Bornhaeuser, Martin
Santarone, Stella
Beelen, Dietrich
Shimoni, Avichai
Roesler, Wolf
Giebel, Sebastian
Savani, Bipin N.
Mohty, Mohamad
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (05) : 767 - 776
[2] Allogeneic stem cell transplantation from unrelated donors in acute leukaemia
Cerrada, Sara Lozano
Altaf, Syed Y.
Olavarria, Eduardo
CURRENT OPINION IN ONCOLOGY, 2018, 30 (06) : 418 - 424
[3] Donor lymphocyte infusion after allogeneic stem cell transplantation
Castagna, Luca
Sarina, Barbara
Bramanti, Stefania
Perseghin, Paolo
Mariotti, Jacopo
Morabito, Lucio
TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (03) : 345 - 355
[4] Pre-emptive and prophylactic donor lymphocyte infusion following allogeneic stem cell transplantation
Harada, Kaito
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (02) : 158 - 168
[5] Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia
Bono, Roberto
Sapienza, Giuseppe
Tringali, Stefania
Rotolo, Cristina
Patti, Caterina
Mule, Antonino
Calafiore, Valeria
Santoro, Alessandra
Castagna, Luca
CELLS, 2024, 13 (09)
[6] Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML
Legrand, F.
Le Floch, A-C
Granata, A.
Fuerst, S.
Faucher, C.
Lemarie, C.
Harbi, S.
Bramanti, S.
Calmels, B.
El-Cheikh, J.
Chabannon, C.
Weiller, P-J
Vey, N.
Castagna, L.
Blaise, D.
Devillier, R.
BONE MARROW TRANSPLANTATION, 2017, 52 (04) : 620 - 621
[7] Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Schmid, Christoph
Labopin, Myriam
Schaap, Nicolaas
Veelken, Hendrik
Brecht, Arne
Stadler, Michael
Finke, Juergen
Baron, Frederic
Collin, Matthew
Bug, Gesine
Ljungman, Per
Blaise, Didier
Tischer, Johanna
Bloor, Adrian
Kulagin, Aleksander
Giebel, Sebastian
Gorin, Norbert-Claude
Esteve, Jordi
Ciceri, Fabio
Savani, Bipin
Nagler, Arnon
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 215 - 223
[8] Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
van der Zouwen, Boris
Koster, E. A. S.
von dem Borne, P. A.
Oosten, L. E. M.
Roza-Scholten, M. W. I.
Snijders, T. J. F.
van Lammeren, D.
van Balen, P.
Marijt, W. A. F.
Veelken, H.
Falkenburg, J. H. F.
de Wreede, L. C.
Halkes, C. J. M.
ANNALS OF HEMATOLOGY, 2023, 102 (05) : 1203 - 1213
[9] Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study
Yang, Luxin
Lai, Xiaoyu
Yang, Ting
Lu, Ying
Liu, Lizhen
Shi, Jimin
Zhao, Yanmin
Wu, Yibo
Chen, Yi
Yu, Jian
Xiao, Haowen
Ouyang, Guifang
Ren, Jinhua
Cao, Junjie
Hu, Yongxian
Tan, Yamin
Ye, Yishan
Cai, Zhen
Xu, Weiqun
Huang, He
Luo, Yi
BONE MARROW TRANSPLANTATION, 2024, 59 (01) : 85 - 92
[10] Factors affecting survival in acute leukemia with donor lymphocyte infusion in the first relapse after allogeneic stem cell transplantation
Kurnaz, Fatih
Sahin, Cem
Kaynar, Leylagul
Pala, Cigdem
Sivgin, Serdar
Altuntas, Fevzi
Eser, Bulent
Cetin, Mustafa
Unal, Ali
JOURNAL OF BUON, 2016, 21 (01): : 227 - 234

← 1 2 3 4 5 →